Patients prefer pictures to numbers to express cardiovascular benefit from treatment
F Goodyear-Smith, B Arroll, L Chan… - The Annals of Family …, 2008 - Annals Family Med
PURPOSE This study aimed to determine which methods of expressing a preventive
medication's benefit encourage patients with known cardiovascular disease to decide to …
medication's benefit encourage patients with known cardiovascular disease to decide to …
Patients' preferences for ways to communicate benefits of cardiovascular medication
F Goodyear-Smith, T Kenealy, S Wells… - The Annals of Family …, 2011 - Annals Family Med
PURPOSE We wanted to determine patients' willingness to take preventive cardiovascular
disease (CVD) medication in relation to their 5-year CVD risk score and modes of …
disease (CVD) medication in relation to their 5-year CVD risk score and modes of …
Influence of cardiovascular risk communication tools and presentation formats on patient perceptions and preferences
AM Navar, TY Wang, X Mi, JG Robinson… - JAMA …, 2018 - jamanetwork.com
Importance Practice guidelines recommend that clinicians engage patients in treatment
decisions and explain atherosclerotic cardiovascular disease (ASCVD) risk but do not …
decisions and explain atherosclerotic cardiovascular disease (ASCVD) risk but do not …
[HTML][HTML] The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial
CLL Carling, DT Kristoffersen, VM Montori… - PLoS …, 2009 - journals.plos.org
Background While different ways of presenting treatment effects can affect health care
decisions, little is known about which presentations best help people make decisions …
decisions, little is known about which presentations best help people make decisions …
[HTML][HTML] How should the impact of different presentations of treatment effects on patient choice be evaluated? A pilot randomized trial
C Carling, DT Kristoffersen, J Herrin, S Treweek… - PLoS …, 2008 - journals.plos.org
Background Different presentations of treatment effects can affect decisions. However,
previous studies have not evaluated which presentations best help people make decisions …
previous studies have not evaluated which presentations best help people make decisions …
What are effective strategies to communicate cardiovascular risk information to patients? A systematic review
CA Waldron, T van der Weijden, S Ludt… - Patient education and …, 2011 - Elsevier
OBJECTIVE: To compare different interventions used to communicate cardiovascular risk
and assess their impact on patient related outcomes. METHODS: A systematic search of six …
and assess their impact on patient related outcomes. METHODS: A systematic search of six …
Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice
CG Harmsen, IS Kristiansen, PV Larsen… - British Journal of …, 2014 - bjgp.org
Background It is important that patients are well-informed about risks and benefits of
therapies to help them decide whether to accept medical therapy. Different numerical …
therapies to help them decide whether to accept medical therapy. Different numerical …
[HTML][HTML] Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey
R Dahl, D Gyrd-Hansen, IS Kristiansen, J Nexøe… - BMC Medical Informatics …, 2007 - Springer
Background For shared decision making doctors need to communicate the effectiveness of
therapies such that patients can understand it and discriminate between small and large …
therapies such that patients can understand it and discriminate between small and large …
Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment?
JE Hux, CD Naylor - Medical Decision Making, 1995 - journals.sagepub.com
Patients' informed acceptance of chronic medical therapy hinges on communicating the
potential benefits of drugs in quantitative terms. In a hypothetical scenario of treatment …
potential benefits of drugs in quantitative terms. In a hypothetical scenario of treatment …
[HTML][HTML] Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners …
S Hill, J Spink, D Cadilhac, A Edwards, C Kaufman… - BMC Public Health, 2010 - Springer
Background Communicating risk is part of primary prevention of coronary heart disease and
stroke, collectively referred to as cardiovascular disease (CVD). In Australia, health …
stroke, collectively referred to as cardiovascular disease (CVD). In Australia, health …